Allscripts Healthcare Stock
Your prediction
Allscripts Healthcare Stock
The Allscripts Healthcare price is unchanged compared to yesterday.
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allscripts Healthcare | 0.000% | 5.882% | 2.857% | -60.870% | -57.647% | -78.571% | -67.857% |
| MicroVision Inc | 1.050% | -5.988% | -4.261% | -3.905% | -51.139% | -69.386% | -77.887% |
| Fonar Corp. New | 0.810% | 0.000% | -0.800% | -16.779% | -12.676% | -23.926% | -18.421% |
| Fluidigm Corp. | 3.280% | 0.826% | 18.447% | -31.073% | -28.655% | -4.464% | -75.403% |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat